222 related articles for article (PubMed ID: 23293354)
1. The B7-independent isoform of CTLA-4 functions to regulate autoimmune diabetes.
Stumpf M; Zhou X; Bluestone JA
J Immunol; 2013 Feb; 190(3):961-9. PubMed ID: 23293354
[TBL] [Abstract][Full Text] [Related]
2. Alternative splice forms of CTLA-4 induced by antisense mediated splice-switching influences autoimmune diabetes susceptibility in NOD mice.
Mourich DV; Oda SK; Schnell FJ; Crumley SL; Hauck LL; Moentenich CA; Marshall NB; Hinrichs DJ; Iversen PL
Nucleic Acid Ther; 2014 Apr; 24(2):114-26. PubMed ID: 24494586
[TBL] [Abstract][Full Text] [Related]
3. Genetic evidence that the differential expression of the ligand-independent isoform of CTLA-4 is the molecular basis of the Idd5.1 type 1 diabetes region in nonobese diabetic mice.
Araki M; Chung D; Liu S; Rainbow DB; Chamberlain G; Garner V; Hunter KM; Vijayakrishnan L; Peterson LB; Oukka M; Sharpe AH; Sobel R; Kuchroo VK; Wicker LS
J Immunol; 2009 Oct; 183(8):5146-57. PubMed ID: 19783679
[TBL] [Abstract][Full Text] [Related]
4. A SNP in the Immunoregulatory Molecule CTLA-4 Controls mRNA Splicing In Vivo but Does Not Alter Diabetes Susceptibility in the NOD Mouse.
Jakubczik F; Jones K; Nichols J; Mansfield W; Cooke A; Holmes N
Diabetes; 2016 Jan; 65(1):120-8. PubMed ID: 26450994
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of the Ctla-4 isoform lacking exons 2 and 3 causes autoimmunity.
Liu SM; Sutherland AP; Zhang Z; Rainbow DB; Quintana FJ; Paterson AM; Sharpe AH; Oukka M; Wicker LS; Kuchroo VK
J Immunol; 2012 Jan; 188(1):155-62. PubMed ID: 22124121
[TBL] [Abstract][Full Text] [Related]
6. T-bet-deficient NOD mice are protected from diabetes due to defects in both T cell and innate immune system function.
Esensten JH; Lee MR; Glimcher LH; Bluestone JA
J Immunol; 2009 Jul; 183(1):75-82. PubMed ID: 19535634
[TBL] [Abstract][Full Text] [Related]
7. Protective regulatory T cell generation in autoimmune diabetes by DNA covaccination with islet antigens and a selective CTLA-4 ligand.
Glinka Y; Chang Y; Prud'homme GJ
Mol Ther; 2006 Oct; 14(4):578-87. PubMed ID: 16790365
[TBL] [Abstract][Full Text] [Related]
8. Immunoinhibitory DNA vaccine protects against autoimmune diabetes through cDNA encoding a selective CTLA-4 (CD152) ligand.
Prud'homme GJ; Chang Y; Li X
Hum Gene Ther; 2002 Feb; 13(3):395-406. PubMed ID: 11860706
[TBL] [Abstract][Full Text] [Related]
9. IL-10 diminishes CTLA-4 expression on islet-resident T cells and sustains their activation rather than tolerance.
Gregg RK; Bell JJ; Lee HH; Jain R; Schoenleber SJ; Divekar R; Zaghouani H
J Immunol; 2005 Jan; 174(2):662-70. PubMed ID: 15634884
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of T cell activation and autoimmune diabetes using a B cell surface-linked CTLA-4 agonist.
Fife BT; Griffin MD; Abbas AK; Locksley RM; Bluestone JA
J Clin Invest; 2006 Aug; 116(8):2252-61. PubMed ID: 16886063
[TBL] [Abstract][Full Text] [Related]
11. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis.
Hussain S; Delovitch TL
J Immunol; 2005 Jan; 174(2):680-7. PubMed ID: 15634886
[TBL] [Abstract][Full Text] [Related]
12. B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets.
Yadav D; Judkowski V; Flodstrom-Tullberg M; Sterling L; Redmond WL; Sherman L; Sarvetnick N
J Immunol; 2004 Sep; 173(6):3631-9. PubMed ID: 15356107
[TBL] [Abstract][Full Text] [Related]
13. Unexpected acceleration of type 1 diabetes by transgenic expression of B7-H1 in NOD mouse peri-islet glia.
Yantha J; Tsui H; Winer S; Song A; Wu P; Paltser G; Ellis J; Dosch HM
Diabetes; 2010 Oct; 59(10):2588-96. PubMed ID: 20522597
[TBL] [Abstract][Full Text] [Related]
14. Cooperative roles of CTLA-4 and regulatory T cells in tolerance to an islet cell antigen.
Eggena MP; Walker LS; Nagabhushanam V; Barron L; Chodos A; Abbas AK
J Exp Med; 2004 Jun; 199(12):1725-30. PubMed ID: 15210748
[TBL] [Abstract][Full Text] [Related]
15. Ctla-4 controls regulatory T cell peripheral homeostasis and is required for suppression of pancreatic islet autoimmunity.
Schmidt EM; Wang CJ; Ryan GA; Clough LE; Qureshi OS; Goodall M; Abbas AK; Sharpe AH; Sansom DM; Walker LS
J Immunol; 2009 Jan; 182(1):274-82. PubMed ID: 19109158
[TBL] [Abstract][Full Text] [Related]
16. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice.
Tian J; Zekzer D; Hanssen L; Lu Y; Olcott A; Kaufman DL
J Immunol; 2001 Jul; 167(2):1081-9. PubMed ID: 11441119
[TBL] [Abstract][Full Text] [Related]
17. Regulatory T Cells Induced by Single-Peptide Liposome Immunotherapy Suppress Islet-Specific T Cell Responses to Multiple Antigens and Protect from Autoimmune Diabetes.
Bergot AS; Buckle I; Cikaluru S; Naranjo JL; Wright CM; Zheng G; Talekar M; Hamilton-Williams EE; Thomas R
J Immunol; 2020 Apr; 204(7):1787-1797. PubMed ID: 32111734
[TBL] [Abstract][Full Text] [Related]
18. Deficiency of the innate immune adaptor STING promotes autoreactive T cell expansion in NOD mice.
Akazawa S; Mackin L; Jhala G; Fynch S; Catterall T; Selck C; Graham KL; Krishnamurthy B; Pappas EG; Kwong CJ; Sutherland APR; Kay TWH; Brodnicki TC; Thomas HE
Diabetologia; 2021 Apr; 64(4):878-889. PubMed ID: 33483762
[TBL] [Abstract][Full Text] [Related]
19. Low expression and secretion of circulating soluble CTLA-4 in peripheral blood mononuclear cells and sera from type 1 diabetic children.
Rydén A; Bolmeson C; Jonson CO; Cilio CM; Faresjö M
Diabetes Metab Res Rev; 2012 Jan; 28(1):84-96. PubMed ID: 22218756
[TBL] [Abstract][Full Text] [Related]
20. An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells.
Vijayakrishnan L; Slavik JM; Illés Z; Greenwald RJ; Rainbow D; Greve B; Peterson LB; Hafler DA; Freeman GJ; Sharpe AH; Wicker LS; Kuchroo VK
Immunity; 2004 May; 20(5):563-75. PubMed ID: 15142525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
